Contact
Victor Thomas
Email
+32 (0)490 08 31 56
iTeos Therapeutics is a publicly-traded (NASDAQ: ITOS), clinical-stage biopharmaceutical company dedicated to extending and improving the lives of patients with cancer by designing and developing next generation immunotherapies.
Based in Gosselies, Belgium and Watertown, MA, iTeos Therapeutics was founded out of the Ludwig Institute for Cancer Research (LICR) and the de Duve Institute (UClouvain) in 2011. As a science-driven company with a robust pipeline, they have successfully completed multiple funding rounds, including a transformative $2.145 billion co-development and co-commercialization agreement with GSK for our anti-TIGIT monoclonal antibody, EOS-448.
As they continue to evolve as a world-class leader in immuno-oncology, they seek highly innovative, proactive, and strategic thinkers to advance their portfolio and lead clinical development efforts. They offer a collaborative, forward-thinking environment where team members are empowered to make significant contributions toward advancing therapies that have the potential to change the standard of cancer care.
Their values - Data Driven, Ownership, Courage, and Stronger Together - form the foundation of who they are as a company and define who they are at their core.
For more information, please visit www.iteostherapeutics.com
iTeos Therapeutics is now a world-class actor in the sector. To carry on its growth and reinforce its team, iTeos Therapeutics is looking for a Research Technician In Vivo.
iTeos Belgium is seeking a highly motivated, proactive and skilled Research Technician to join the In Vivo Biology group in our Research and Development Department. The successful candidate will be responsible for supporting daily activities at the animal facility, including maintenance of facility installations, colony management, control of stock & supplies, maintaining sanitary vigilance as well as animal inoculation, treatment, monitoring and sample collections.
Your main responsibilities are:
Your application and related information will remain strictly confidential.